Product Images Aripiprazole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Aripiprazole NDC 43547-303 by Solco Healthcare U.s., Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

2f5cad93-figure-02 - 2f5cad93 figure 01

2f5cad93-figure-03 - 2f5cad93 figure 02

The text describes the effect of different drugs on aripiprazole and provides data on the fold change and 90% CI of PK Avipiprazole. It includes the class of drugs such as CYP3A4 inhibitors, nmns inhibitors and CYP3AA inducers along with specific drugs and their corresponding fold change values. The data presented could be useful in understanding the impact of co-administering aripiprazole with other drugs.*

2f5cad93-figure-04 - 2f5cad93 figure 03

This text provides information on the effect of different drugs on the pharmacokinetics of aripiprazole. It includes data on fold changes and 90% confidence intervals for dehydro-aripiprazole levels when co-administered with drugs that inhibit or induce CYP enzymes or block gastric acid. The text also mentions the effect of valproate and lorazepam on aripiprazole.*

C:\Users\RA\Desktop\aripiprazole-plr\figure 4.png - 2f5cad93 figure 04

$C:\Users\RA\Desktop\aripiprazole-plr\figure 4.png - 2f5cad93 figure 04$

This text seems to be a table showing the effect of Aripiprazole on the AUC and Cmax of other drugs such as omeprazole, valproate, lorazepam, venlafaxine, and others. The table displays the fold change and 90% confidence interval. No further information or context is available.*

C:\Users\RA\Desktop\aripiprazole-plr\figure 5.png - 2f5cad93 figure 05

$C:\Users\RA\Desktop\aripiprazole-plr\figure 5.png - 2f5cad93 figure 05$

This text appears to be a table with headings for "Special Populations", "Age", "Hepatic impairment", and "Renal impairment". The table contains various levels of impairment and related rates. The last section includes a graph with "Aripiprazole Fold Change and 30% CI" headings. It is unclear what the graph represents without additional information.*

C:\Users\RA\Desktop\aripiprazole-plr\figure 6.png - 2f5cad93 figure 06

$C:\Users\RA\Desktop\aripiprazole-plr\figure 6.png - 2f5cad93 figure 06$

2f5cad93-figure-08 - 2f5cad93 figure 07

2f5cad93-figure-09 - 2f5cad93 figure 08

C:\Users\RA\Desktop\3.jpg - arpiprazole 10mg 100count

$C:\Users\RA\Desktop\3.jpg - arpiprazole 10mg 100count$

C:\Users\RA\Desktop\4.jpg - arpiprazole 15mg 100count

$C:\Users\RA\Desktop\4.jpg - arpiprazole 15mg 100count$

This is a package label for a medication called Aripiprazole Tablets, USP manufactured by Zrejan Hushsi Phamceuta Co. L in Xangan, Zrefang, China. The storage instructions indicate that the medicine should be stored in a closed container at room temperature between 20°C and 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). The label also lists a distributor named Soka et US, LIC based in Somaret, NJ 06675, USA.*

C:\Users\RA\Desktop\5.jpg - arpiprazole 20mg 100count

$C:\Users\RA\Desktop\5.jpg - arpiprazole 20mg 100count$

C:\Users\RA\Desktop\1.jpg - arpiprazole 2mg 100count

$C:\Users\RA\Desktop\1.jpg - arpiprazole 2mg 100count$

C:\Users\RA\Desktop\6.jpg - arpiprazole 30mg 100count

$C:\Users\RA\Desktop\6.jpg - arpiprazole 30mg 100count$

C:\Users\RA\Desktop\2.jpg - arpiprazole 5mg 100count

$C:\Users\RA\Desktop\2.jpg - arpiprazole 5mg 100count$

C:\Users\RA\Desktop\aripiprazole-plr\structure.jpg - structure

$C:\Users\RA\Desktop\aripiprazole-plr\structure.jpg - structure$

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.